Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse-Remitting Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01667796
What this trial is testing

Pharmacokinetics of Vitamin D in Multiple Sclerosis and in Health

Who this might be right for
Multiple Sclerosis, Relapsing-remitting
Johns Hopkins University 57
Large-scale testing (Phase 3)Study completedNCT00276341
What this trial is testing

Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Ipsen 47
Very early researchStudy completedNCT00618527
What this trial is testing

Combination Therapy Using Cellcept and Rebif in RRMS

Who this might be right for
Multiple Sclerosis
Aaron Boster 31
Not applicableStudy completedNCT05335031
What this trial is testing

A Study Investigating the Utilization, Effectiveness and Quality of Life in Clinical Practice in Germany for Participants With Relapsing-remitting Multiple Sclerosis Treated With Ozanimod (Zeposia®)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bristol-Myers Squibb 450
Large-scale testing (Phase 3)Study completedNCT05242133
What this trial is testing

Efficacy and Safety of Peginterferon Beta-1a (CinnaGen) in Participants With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)
Cinnagen 168
Large-scale testing (Phase 3)Looking for participantsNCT04047628
What this trial is testing

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

Who this might be right for
Relapsing Multiple SclerosisRelapsing Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 156
Early research (Phase 1)Study completedNCT06430671
What this trial is testing

Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis (RRMS)
Cellerys AG 11
Not applicableStudy completedNCT00391352
What this trial is testing

FMRI Study of Treatment Recommendations Comparing Recently Diagnosed Multiple Sclerosis (MS) Patients to Controls

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Waukesha Memorial Hospital 21
Not applicableStudy completedNCT04972929
What this trial is testing

Effects of Chiropractic Care on Cytokine Levels in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
University of Alabama at Birmingham 26
Not applicableStudy completedNCT00819195
What this trial is testing

Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of California, San Francisco 17
Large-scale testing (Phase 3)Active Not RecruitingNCT04578639
What this trial is testing

Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Haukeland University Hospital 214
Not applicableLooking for participantsNCT05962177
What this trial is testing

Montpellier PROspective Cohort in Relapsing Remitting Multiple Sclerosis Using Imaging and Serologic

Who this might be right for
Multiple Sclerosis
University Hospital, Montpellier 400
Not applicableWithdrawnNCT02419638
What this trial is testing

Comparison of Rebif Compared to Tecifdera on Six-month Outcomes in Patients With Relapsing-remitting MS

Who this might be right for
Multiple Sclerosis
Brigham and Women's Hospital
Not applicableStudy completedNCT01592097
What this trial is testing

Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS

Who this might be right for
Multiple Sclerosis
University of Southern California 51
Testing effectiveness (Phase 2)Study completedNCT00525668
What this trial is testing

Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Charite University, Berlin, Germany 120
Testing effectiveness (Phase 2)Study completedNCT00395317
What this trial is testing

Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
GlaxoSmithKline 343
Not applicableStudy completedNCT02647502
What this trial is testing

A Pilot Study of Intermittent Calorie Restriction in Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Johns Hopkins University 36
Testing effectiveness (Phase 2)Study completedNCT00203112
What this trial is testing

Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline

Who this might be right for
Relapse Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 44
Not applicableNot Yet RecruitingNCT07372599
What this trial is testing

Influence of Therapeutic Failure on the Psychosocial Experience in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University Hospital, Caen 150
Very early researchStudy completedNCT03498131
What this trial is testing

Melatonin in Patients With Multiple Sclerosis (MS).

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Providence Health & Services 30
Next Page